INTRODUCTION
The phylum Nematoda comprises a large, diverse group of invertebrate organisms occupying a range of habitats, both free-living and parasitic, more varied than any other animals except arthropods (4) . Within their ranks are species not only responsible for several of the most debilitating chronic diseases of man, i.e. filariasis (lymphatic and onchocerciasis), ascariasis and hookworm, but also for significant economic losses resulting from parasitaemias of domestic animals (82) . In ruminants, severe gastro enteritis with accompanying anaemia can result from colonisation of the abomasum with Haemonchus contortus, Trichostrongylus axel and Ostertagia spp.; Trichostrongylus, Cooperia, Nematodirus and Strongyloides spp. in the small intestine; and Oesophagostomum spp., Chabertia ovina and Trichuris spp. in the caecum and colon (37) . In addition to economic losses incurred through morbidity and mortality of affected livestock, nematode parasitic zoonoses, most prominently represented by Trichinella spp., are a public health concern. Because human trichinosis is acquired exclusively through the ingestion of raw, undercooked or unprocessed meat products (51) , the persistence of infective Trichinella spiralis larvae in domestic and sylvatic reservoirs worldwide presents a continued challenge to the successful implementation of immunodiagnostic and immunoprophylactic measures.
Thus, if an ultimate goal for today's immunoparasitologist is to produce safe, efficacious vaccines that will protect man and domestic animals from the detrimental effects of targeted parasitaemias (50, 71, 78) , then the need for rapid, reproducible diagnostic assays that can accurately assess the development of protective immunity against specific parasites is crucial. The progress made, as well as the setbacks encountered, in combating nematode infections is the focus of this review. For illustrative purposes, research methodologies and control strategies employed for the control of Trichinella zoonosis will be offered as examples of the practical deployment of this rationale.
IMMUNODIAGNOSIS
Although a definitive diagnosis of trichinosis in man, domestic swine or sylvatic species is achieved ultimately through the demonstration of the infective first stage L1 larvae in the musculature (61, 91) , serological evidence of either active infection with, or prior exposure to, the parasite provides confirmatory evidence in the case of suspected human illness and yields valuable epidemiological information concerning the domestic and wildlife species responsible for its transmission. In any parasitic disease, the identification, isolation and characterisation of antigens that are both parasite-specific and immunogenic in the infected host is critical for the development of accurate methods of serodiagnosis (8) . In 1911, Strobel (75) reported antigenic activity in extracts prepared from T. spiralis L1; in the interim, numerous reports describing the antigenicity of crude worm extracts have been cited (reviewed in 34, among others). These polyvalent antigenic preparations have been employed for the detection of circulating antibody in a broad array of immunodiagnostic assays, including indirect immunofluorescence (30, 68) , passive haemagglutination (33), bentonite flocculation (69) and the enzyme-linked immunosorbent assay, or ELISA (21) . By parasitological parameters, the ELISA can detect levels of infection as low as 0.01 larvae per gram (LPG), compared with 1.0 LPG by pepsin digestion and 3.0 LPG by trichinoscopic methods (23, 53, 66) .
Perhaps the best characterised antigens, however, are the metabolic antigens elaborated by the L1 (17) . Originally demonstrated by Campbell (13) and further described by Mills and Kent (49), these excretory-secretory products, or ES antigens, were later shown by ultrastructural methods to be the released granule contents of the alpha and beta stichocytes (19) . Hyperimmune rabbit sera recognise at least twenty distinct antigenic moieties in the elaborated ES products, which exhibit a broad spectrum of molecular weights and isoelectric points (18) . To select antigens of potential diagnostic value from this complex array, several groups have employed affinity chromatography (8, 24, 70, 72) . When the diagnostic efficacy of (i) a crude, lipid-free extract of pepsin-isolated muscle larvae (XM-300), (ii) a partially purified protein fraction enriched in the stichocyte secretory granules (S3), and (iii) the S3 fraction passed through an affinity column charged with hyperimmune rabbit sera was evaluated by ELISA, the affinity-purified S 3 fraction was found to be antigenically superior to the more crude preparations in its sensitivity, specificity and earlier detection of T. spiralis-specific antibodies in the sera of experimentally and naturally infected pigs (24, 70) .
Although the persistence of nematodes in an apparently immunocompetent host was originally attributed to possession of an antigenically inert cuticle (38) , it is now known that the majority of parasites elicit humoral responses to the proteins displayed on their surface (56) , as well as to secreted products, such as those discussed above. Parkhouse et al. (60) reported a sodium dodecyl sulfate-poly-acrylamide gel profile of the surface-labelled proteins of T. spiralis L1, electrophoresed under reducing conditions, which consisted of two doublets of apparent m.w. of 47 and 55 kD, and 90 and 105 kD. The production of a monoclonal antibody (NIM-M1) which precipitates all four surface proteins detected by radioiodination (59) suggests the presence of a common antigenic determinant on these molecules suitable for incorporation in an immunodiagnostic assay. Recently, Arriaga et al. (8) reported the results of longitudinal studies conducted on both experimentally and naturally infected pigs to identify T. spiralis antigens recognised during the course of infection. Because the principal antigens identified by immune sera corresponded to the major surface/stichosomal proteins recognised by the NIM-M1 monoclonal antibody, these antigens were purified by affinity chromatography, and evaluated for their immunodiagnostic potential following Western blot analysis and ELISA (8) . In 295 serum samples from field-infected and uninfected backyard pigs in three different geographic regions of Mexico, a greater signal-to-noise ratio was obtained with the purified stichosomal or ES products than with soluble extracts (8) .
Thus, the use of more defined muscle larval antigens from the stichosome or its secretions has significantly improved the specificity of the ELISA for the diagnosis of swine trichinosis. Evaluation of the ELISA employing the L1 ES antigen developed by Gamble et al. (23) has been performed on infected herds in the United States (53) . As a result of these studies, in which the ELISA exhibited a 96% detection rate with 100% specificity, the L1 ES ELISA has been commercialised (Idetek, Inc.). Although the test is commonly used for epidemiological studies in the United States, there is great interest in utilising the assay for the ante-mortem inspection of hogs at the slaughterhouse. To that end, a large-scale trial was conducted in 1987 in a commercial slaughterhouse; 20,000 market hogs were tested by both the ELISA and by tissue digestion (57) . In this trial, the ELISA detected 98% of the porcine infections with muscle larval burdens capable of inducing clinically significant illness in humans (57) . Based on these findings, a petition to permit the ELISA to be used for inspection purposes has been filed with the United States Department of Agriculture (USDA) regulatory agencies; these agencies are currently reviewing the request.
The variability inherent in the antigenic yield obtained by any of the methods detailed above, however, continues to thwart large-scale attempts at standardisation. To circumvent this difficulty, Zarlenga and Gamble (90) constructed a cDNA expression library in lambda gt11 with poly A mRNA isolated from T. spiralis muscle larvae. By screening for antibody binding with either serum from a T. spiralis-infected pig, or serum from a rabbit immunised with ES products, a cDNA clone (TsA-12) that reacted strongly with both antisera was identified (90) . Rabbit antibodies raised against the purified recombinant protein were analysed using a Western blot technique (12) to identify homologous proteins in an extract of T. spiralis, and were found to interact with a doublet of 53,000 kD, corresponding to one of the major immunodiagnostic antigens in T. spiralis. To assess the suitability of the TsA-12 antigen as a diagnostic reagent, the purified recombinant protein was tested in an ELISA using rabbit antiserum as the primary antibody, and was found to equal, if not surpass, the ES preparation in sensitivity at a ten-fold lower antigen concentration (90) . TsA-12 also successfully discriminated between sera from swine infected with A. suum, T. suis or T. spiralis; however, the relatively low ratio obtained for positive vs. negative sera (4.5 : 1) in this assay may result from circulating high antibody titres to common bacterial pathogens present in the sera of naturally infected swine (90) .
Although the application of immunological methods to the diagnosis of trichinosis has monitored, for the most part, the development of the host's humoral antibody response (36) , it has been demonstrated recently that circulating antigens can be detected in the blood of human patients (14) . To further investigate the feasibility of this approach, Ivanoska et al. (29) assayed the sera of 101 individuals, obtained during several epidemic outbreaks of trichinosis in Yugoslavia between 1985 and 1987, for circulating T. spiralis antigens by an immunoradiometric assay (IRMA), and T. spiralis-specific antibodies by indirect immunofluorescence (IIF) and a competitive inhibition assay (CIA). By these methods, ES antigens were detected in the sera of 47% of 62 patients with clinical trichinosis, and in 13% of the 39 patients without clinical signs but suspected of exposure to infected meat (29) . By comparison, T. spiralis-specific antibodies were detected in 100% of the 62 patients with clinical trichinosis, and in 46% of the 39 patients at high risk for infection but without clinical signs (29) . Thus, while antibody detection remains the more sensitive method for the diagnosis of trichinosis in humans, an improved assay for the detection of circulating T. spiralis antigens may be a useful confirmatory test, because it provides a direct demonstration of the presence of metabolically active parasites in the affected host, without sampling biopsied tissue. Such an assay may also have applicability in the screening of large herds of domestic swine, especially in high-risk endemic areas both in the USA and abroad (51), but would not supplant the antibody-based ELISA unless it were to achieve comparable levels of sensitivity and specificity.
EMMUNOBIOLOGY
Although the development of a rapid, reproducible and sensitive diagnostic assay for the identification of a host either actively infected with, or previously exposed to, infection serves as a necessary adjunct to the evaluation of any proposed vaccination or epidemiological study, immunodiagnostic methods alone cannot adequately predict the outcome of an encounter between a given parasite and a potential host. Rather, what is required is a more complete understanding of the ways in which parasites have evolved to survive and reproduce in an immunologically hostile alien environment. Such mechanisms of immune evasion can be broadly categorised as follows: anatomic seclusion, modification of antigenicity, or inactivation of host effector function (55, 71) . Selected examples of host-parasite interactions that illustrate the deployment of these mechanisms in vivo will be discussed below, with special emphasis on the life cycle of T. spiralis.
T. spiralis may be viewed as a highly successful parasite in that it can establish, develop and reproduce in a wide range of mammalian hosts (80) . Such low host specificity may reflect either an innate adaptive flexibility of the parasite to withstand variable physiologic environmental conditions, or an impressive array of deceits designed to counter the elicited immune response of the host. T. spiralis is also unusual in that, unlike the majority of parasitic helminths (43) , it completes its life cycle in a single host; this may offer a selective advantage to the parasite by eliminating the need for vectors, intermediate hosts or changing environmental conditions to produce the next generation. Infection begins with the ingestion of infective L1 larvae encysted in the striated skeletal muscle of the previous host; digestion of consumed tissue by gastric enzymes releases the L1 larvae, which rapidly enter the columnar epithelium of the intestinal villi (89) to undergo four moults within 30 hours (1, 35, 76) . Approximately five days after mating in the enteral niche, adult female worms begin to release newborn larvae, which migrate through the lamina propria, enter the lymphatics and eventually reach the bloodstream (9, 28, 81) . The next intracellular phase in the T. spiralis life cycle begins with the penetration of the sarcolemma by the newborn larva (15) ; during the next twenty days, the newborn larva increases its volume over 270 times, while inducing a dramatic transformation of the host myofibril to form what is termed a nurse cell (65) . The resulting nurse cell-L1 complex can remain in a stable, infectious configuration indefinitely, provided that its cyst is not calcified by the current host (16) .
A cursory examination of the life cycle of T. spiralis provides an example of parasite evasion through anatomic seclusion. Except for a brief stay in the stomach at the time of the initial infection, the only other interval in which the parasite does not reside intracellularly is during the migration of the newborn larvae from the intestinal villi through the lymphatics and the vascular system to the musculature (16, 81) . The sequestration of the parasite during most of its life cycle does not, however, ensure protection from the host's immune defense mechanisms. In rodents, for example, enhanced expulsion of larval and adult worms from the gut, in conjunction with anti-fecundity effects, constitutes the major host protective responses to secondary infection with T. spiralis (2, 3, 11) . Although gut expulsion of adult T. spiralis is delayed in onset and reduced in intensity in swine (and man) in response to both primary and secondary T. spiralis infections (52), studies performed in outbred swine have strongly implicated an antibody-mediated response directed against the newborn larvae as a critical component in protective immunity (45) . Although once considered to be dormant and essentially non-immunogenic, the liberation of antigenic molecules from actively metabolising encysted T. spiralis muscle larvae was suggested by (i) the perturbations observed in the metabolism of infected muscle fibres (73), (ii) increases in amino acid uptake (27) and (iii) RNA metabolism (74) . These findings were extended by Pritchard (64) , who demonstrated the presence of antigen-bearing mononuclear cells within the cysts at 28 days post-infection, and confined to the outer boundary of the cysts by 50 days post-infection. Recently, Madden et al. (42) described a marked reduction, upon homologous challenge infection, in the number of encysted muscle larvae that had been established during a primary infection of SLA (an acronym for Swine Leukocyte Antigen) inbred miniature swine. These in vivo observations of host intervention at various points in the parasite life cycle complement the accrued in vitro evidence for the stage-specific antigenicity of T. spiralis. Mackenzie et al. (41) were able to remove antibodies mediating the adherence of eosinophils to infective Lj larvae by preabsorbing infected sera with this stage of the parasite. Philipp et al. (63) demonstrated the stage-specific expression of surface-labelled proteins of T. spiralis by autoradiography, and later work by Jungery et al. (32) revealed that the gel profile of detergent-solubilised, surface-iodinated proteins of newborn larvae changed dramatically within 6-8 hours after release from the adult female (4). This alteration of the newborn larval antigenic profile was further substantiated by Ortega-Pierres et al. (58, 59) , who generated a monoclonal antibody that bound only newly released larvae, as determined by immunofluorescence.
Even though T. spiralis exhibits both anatomic exclusion and modification of its antigenicity, it still triggers an extensive series of immunological responses in the host. Thus, the induction of a parasite-specific immune response need not correlate with the host's ability to reject or kill the parasite, or to limit the parasite's ability to establish, develop or reproduce (86) . Whether or not these immune defense mechanisms are sufficient to prevent or terminate the infection may be determined, to a large extent, by the genetic composition of the host.
The relative contributions of genes within and beyond the major histocompatibility complex (MHC) to the final outcome of an encounter between a permissive host and an opportunistic parasite are difficult to assess; perhaps nowhere is this tenet more strikingly evident than in the designation of responder and nonresponder phenotypes in rodent models of primary and secondary infection with T. spiralis (79, 86) . Work by Wassom and colleagues (84), employing congenic mice expressing different MHC (H-2) haplotypes in the context of a common B10 background, first demonstrated an association between the expression of certain alleles of genes within the MHC, and the degree of resistance or susceptibility to primary infection with T. spiralis. Further studies with recombinant H-2 strains resulted in the identification of two genes, termed Ts-1 and Ts-2, which clearly influence the host response to T. spiralis, and map to the class II region (Ts-1), and between the S-and D-regions of class I (Ts-2) (83, 85) . Thus, expression of s, q, f, or b alleles at the Ts-1 locus is associated with increased resistance to infection, whereas expression of the d allele at Ts-2 greatly increases the host's susceptibility to infection (83, 85) as measured by the total muscle larval (ML) burdens thirty days after primary infection. The influence of MHC genes on other parameters of the rodent response to T. spiralis infection, however, is less apparent; Bell et al. (10) have identified an autosomal dominant gene; designated Ihe-1, which is not linked to the MHC, yet appears important in the manifestation of the gut expulsion response discussed earlier. To further complicate the assignment of responder/nonresponder status in this system, Wassom et al. (87) have described a dose-dependent suppression of immunity to T. spiralis, whereby significant H-2 associated differences in either in vitro antigen-specific lymphocyte blastogenesis or in vivo expulsion of adult worms were evident only at low infective doses and were not seen in mice receiving an oral infection of 400 or 600 L1.
Although empirical observations regarding the differential resistance of domestic species to helminth infections have been recorded for some time, systematic experimental analysis of the source and heritability of this variation has been relatively recent (79) . The pig is unique among livestock in that inbred animals defined at their MHC (the SLA) have been developed (67, 77) . The SLA inbred miniature swine, or NIH minipigs, express three independent SLA haplotypes, designated as SLA a (a), c, and d (40) . Work by Lunney and Murrell (39) revealed that after a low level primary infection with T. spiralis, homozygous cc pigs developed a 50% lower ML burden than homozygous dd or aa pigs. The relative resistance of the cc pig to primary infection with T. spiralis correlated with earlier serum antibody reactivity, and heightened cellular blastogenesis to T. spiralis antigens (39) . Because these data suggested that swine, like rodents, exhibited MHC-regulated responses to primary infections with T. spiralis, further studies were performed to examine the influence of SLA phenotype on the secondary response to this parasite. In these experimental trials, challenged pigs of all three SLA phenotypes were protected against secondary infection with T. spiralis; however, only aa pigs exhibited a highly significant reduction after challenge (p < 0.0003) in the encysted ML established during the primary infection (42) .
The heritability of resistance to infection with Haemonchus contortus, which causes a severe nematodiasis in sheep, was first described by Whitlock (88) , who observed that the offspring of a given ram were somewhat less susceptible to infection than lambs sired by other rams in the same flock. More recently, Alpers et al. (5) and Gray (26) have followed experimental haemonchosis over time in a flock of sheep grouped by sire, and have arrived at an estimate of heritability for resistance to infection of 29% (as determined by faecal counts) and 18% (as reflected in growth gains). As observed within breeds, there are also significant differences in resistance to H. contortus between breeds of sheep. Altaif and Dargie (6, 7), for example, have performed comparative analyses on the relative resistance of Scottish Blackface and Finn Dorset sheep to experimental infection with this parasite. In these studies, the Blackface sheep retained fewer adult worms after a primary infection, and resolved a secondary infection by rapid expulsion more quickly, than similarly treated Finn Dorsets (6, 7). Table I , reproduced from Wakelin (79), gives a partial listing of the multiple parameters associated with resistance to certain parasitic infections thought to have a significant genetic component. 
Host

VACCINE DEVELOPMENT
The genetic propensity of a given host species, and individual members of that species, to resistance or susceptibility to infection with a particular parasite, also plays a significant role in determining the efficacy of vaccines designed to confer protection against these infectious agents. Despite the general consensus recognising the need for effective vaccines in this area, it has not yet been possible to develop a vaccine that successfully prevents any of the major human parasitic diseases (71) . Before discussing the veterinary vaccines involving the use of attenuated parasites, namely Ancylostoma caninum against hookworm in dogs, and Dictyocaulus filaria against lungworm in cattle, and prospective applications for vaccines in the strategic control of trichinosis, it is important to bear in mind the special problems encountered in both the development and the deployment of parasite vaccines. G.F. Mitchell (50) has categorised these difficulties in relation to (i) structural and life-cycle complexity of the parasite, (ii) the chronicity of infection apparent in numerous helminth and protozoan diseases and (iii) demonstrable efficacy in experimental trials. A note of optimism regarding the last category has been proffered by Mahmoud (43) and others, who observe that most helminths do not multiply within their definitive host, that a small proportion of infected individuals harbour a high number of parasites and that morbidity is related to the magnitude of the parasite burden. A vaccine conferring less than 100% protection under these circumstances may exert a significant biological and clinical effect.
Irradiated larval vaccines have been developed and tested for efficacy against two parasitic nematodes, namely D. viviparus (cattle lungworm) and A. caninum (dog hookworm). The former was developed in 1960 (31, 62) and the latter soon after (47, 48) . As described by Maizels and Selkirk (44) , however, production of the irradiated vaccines presented significant logistic problems, which rendered them economically unfeasible for profitable commercial marketing.
As discussed above, the antigens of the various life-cycle stages of T. spiralis have been the subject of considerable scrutiny and, as a result, are comparatively well understood. In rodent models of infection, it has been demonstrated that both crude somatic extracts and ES products are highly protective (55) . A successful immunisation of rats with a purified T. spiralis antigen was conducted by Durham et al. (20) with an allergen isolated from T. spiralis L1; later work suggested that this protective allergen (antigen) originated from the stichosome. Although T. spiralis antigens derived from the muscle larval stichosome have been tested in swine (25, 54) , their protective efficacy in this host is low to moderate, in contrast to that observed for rodents (20, 22, 72) . This dichotomy posed a serious obstacle to the development of a vaccine strategy for swine, and, in turn, stimulated a serious effort to understand the differences in protective immunity against T. spiralis exhibited by these two host species. An important revelation in this regard was the observation that unlike mice and rats, swine develop only a moderate degree of intestinal immunity (52) . Marti and Murrell (45) demonstrated that in swine, the most effective protective mechanism is an IgG antibody response to the migrating newborn larvae (NBL), ostensibly directed against stage-specific antigens. Subsequently, Marti et al. (46) reported success in inducing high levels of protection in swine with both killed NBL and with the insoluble aqueous fraction of the larvae. This approach has produced up to 90% protection in vaccinated swine, as measured by reduced survival of challenge larvae in the musculature. Recent attempts to increase the degree of protection conferred by the NBL vaccine, through the incorporation of muscle larval ES, have not demonstrated unequivocally that such an antigen "cocktail" offers significant improvement (A. Marinculic, H.R. Gamble and K.D. Murrell, manuscript in preparation).
Before commencing large-scale in vitro generation of NBL for vaccine production, it is critical to assess the efficacy of the proposed immunogen under natural conditions. The initial field trials for the said vaccine will be conducted in Yugoslavia, where certain geographic regions exhibit relatively high transmission rates of trichinosis in swine (these trials are expected to be completed by 1992). Should the vaccine prove to be effective, a greater effort will be directed towards reducing the labour and cost involved in its production.
Thus, the prospects for the development of a vaccine against trichinosis in swine are encouraging. It is our belief, however, that immunisation with such a vaccine would not be indicated for all swine under normal production conditions. Rather, we envision a more selective deployment which targets problem foci as part of an overall management strategy designed to eliminate the parasite only where it is detected. 
